GDF-15 is also called as nonsteroidal anti-inflammatory drug (NSAID) activated gene-1 (NAG-1), because it was identified as an NSAID-induced gene based on the evidence that the development of colon cancer was prevented by the administration of NSAIDs16,17. This evidence concerns the gene GDF15 and malignant colon neoplasm.